Delivery Order SPE2DB20D1100-SPE2DB25FB2A7
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,684.12, is for the delivery of 4567501343 - LISDEXAMFETAMINE 40 MG CAPSULE 100S. The contract type is a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of March 6, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,783.60 Firm Fixed Price delivery order contract is for the supply of 4567113134 LISDEXAMFETAMINE 30 MG CAPSULE 100S, which will be delivered by January 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,070.16, is for the delivery of LISDEXAMFETAMINE 30 MG CAPSULE 100S. This is a firm fixed-price delivery order contract with a performance period through March 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,070.16, is a delivery order for the supply of 4567491553 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. The award is not associated with a set-aside program and has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,426.88, is for the delivery of 4567502070 - LISDEXAMFETAMINE 40 MG CAPSULE 100S. The contract has an ultimate completion date of March 10, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $2,328.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567038547 - LISDEXAMFETAMINE 20 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $15,076.16, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566963272 - LISDEXAMFETAMINE 40 MG CAPSULE 100S, a prescription medication, with a period of performance through January 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,599.67 firm-fixed-price delivery order is for the supply of LISDEXAMFETAMINE 50 MG CAPSULE 100S, with a completion date of May 28, 2025. The contract is not set-aside and was awarded on May 27, 2025. Amerisourcebergen Drug Corp is a for-profit organization and holds a significant $999,999,999.00 Indefinite...
- This federal contract award, valued at $3,114.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567669382 - LISDEXAMFETAMINE 50 MG CAPSULE 100S, a prescription medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award, valued at $3,718.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4567239595 ! LISDEXAMFETAMINE 40 MG CAPSULE 100S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement with a completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FB2A7Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,885.97, is for the delivery of 4567615863 - LISDEXAMFETAMINE 40 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 19, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 3/18/25 |